Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project U-PGx. Just KS, Steffens M, Swen JJ, Patrinos GP, Guchelaar HJ, Stingl JC. Eur J Clin Pharmacol. 2017 Oct;73(10):1247-1252. Posted on May 15, 2019May 15, 2019 by Wendy van Hemmen Continue reading →
Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients. Chondrou V, et al., Katsila T, Patrinos GP. Hum Genomics. 2017 Oct 23;11(1):24. Posted on May 15, 2019May 15, 2019 by Wendy van Hemmen Continue reading →
Pitfalls and Opportunities for Epigenomic Analyses Focused on Disease Diagnosis, Prognosis, and Therapy. Lauschke VM, Ivanov M, Ingelman-Sundberg M. Trends Pharmacol Sci. 2017 Sep;38(9):765-770. Posted on April 24, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Exploring public genomics data for population pharmacogenomics. Lakiotaki K, Kanterakis A, Kartsaki E, Katsila T, Patrinos GP, Potamias G. PLoS One. 2017 Aug 3;12(8):e0182138. Posted on April 24, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen. Manson LE, van der Wouden CH, Swen JJ, Guchelaar HJ. Pharmacogenomics. 2017 Jul;18(11):1041-1045. Posted on April 24, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Performance Ratio Based Resource Allocation Decision-Making in Genomic Medicine. Fragoulakis V, Mitropoulou C, Katelidou D, van Schaik RH, Maniadakis N, Patrinos GP. OMICS. 2017 Feb;21(2):67-73. Posted on April 24, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels. Tremmel R, Herrmann K, Engst W, Meinl W, Klein K, Glatt H, Zanger UM. Arch Toxicol. 2017 Oct;91(10):3329-3339. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation. Katsila T, Matsoukas MT, Patrinos GP, Kardamakis D. OMICS. 2017 Aug;21(8):429-439. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics. Sarris K, Komianou A, Patrinos GP, Katsila T. Public Health Genomics. 2017;20(2):142-147. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
Exosomes: A Cancer Theranostics Road Map. Panagiotara A, Markou A, Lianidou ES, Patrinos GP, Katsila T. Public Health Genomics. 2017;20(2):116-125. Posted on April 18, 2018May 14, 2019 by Wendy van Hemmen Continue reading →
